These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 37991922)
1. Optogenetic-mediated induction and monitoring of α-synuclein aggregation in cellular models of Parkinson's disease. Teixeira M; Sheta R; Idi W; Oueslati A STAR Protoc; 2023 Dec; 4(4):102738. PubMed ID: 37991922 [TBL] [Abstract][Full Text] [Related]
2. Optogenetic induction of alpha-synuclein aggregation in human dopaminergic neurons to model Parkinson's disease pathology. Ra EA; Kim MS; Lee G STAR Protoc; 2023 Dec; 4(4):102609. PubMed ID: 37742181 [TBL] [Abstract][Full Text] [Related]
3. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia. Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690 [TBL] [Abstract][Full Text] [Related]
4. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration. Oliveras-Salvá M; Van der Perren A; Casadei N; Stroobants S; Nuber S; D'Hooge R; Van den Haute C; Baekelandt V Mol Neurodegener; 2013 Nov; 8():44. PubMed ID: 24267638 [TBL] [Abstract][Full Text] [Related]
5. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy. Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813 [TBL] [Abstract][Full Text] [Related]
6. Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation. Panattoni G; Rota L; Colla E J Vis Exp; 2018 Jun; (136):. PubMed ID: 30010663 [TBL] [Abstract][Full Text] [Related]
7. α-Synuclein and Lewy pathology in Parkinson's disease. Kalia LV; Kalia SK Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807 [TBL] [Abstract][Full Text] [Related]
8. Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease. Guo M; Wang J; Zhao Y; Feng Y; Han S; Dong Q; Cui M; Tieu K Brain; 2020 May; 143(5):1476-1497. PubMed ID: 32355963 [TBL] [Abstract][Full Text] [Related]
9. Amyloid aggregates of the deubiquitinase OTUB1 are neurotoxic, suggesting that they contribute to the development of Parkinson's disease. Kumari R; Kumar R; Kumar S; Singh AK; Hanpude P; Jangir D; Maiti TK J Biol Chem; 2020 Mar; 295(11):3466-3484. PubMed ID: 32005664 [TBL] [Abstract][Full Text] [Related]
10. The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells. Fares MB; Ait-Bouziad N; Dikiy I; Mbefo MK; Jovičić A; Kiely A; Holton JL; Lee SJ; Gitler AD; Eliezer D; Lashuel HA Hum Mol Genet; 2014 Sep; 23(17):4491-509. PubMed ID: 24728187 [TBL] [Abstract][Full Text] [Related]
11. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease. Sharma N; Rao SP; Kalivendi SV Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974 [TBL] [Abstract][Full Text] [Related]
12. Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson's disease. Hideshima M; Kimura Y; Aguirre C; Kakuda K; Takeuchi T; Choong CJ; Doi J; Nabekura K; Yamaguchi K; Nakajima K; Baba K; Nagano S; Goto Y; Nagai Y; Mochizuki H; Ikenaka K Sci Rep; 2022 Jan; 12(1):351. PubMed ID: 35013421 [TBL] [Abstract][Full Text] [Related]
13. Detection of pathological alpha-synuclein aggregates in human iPSC-derived neurons and tissue. Stojkovska I; Mazzulli JR STAR Protoc; 2021 Mar; 2(1):100372. PubMed ID: 33733241 [TBL] [Abstract][Full Text] [Related]
14. How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease? Volpicelli-Daley LA; Kirik D; Stoyka LE; Standaert DG; Harms AS J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):131-155. PubMed ID: 27018978 [TBL] [Abstract][Full Text] [Related]